Generic Semaglutide contains the same active molecule as Ozempic / Wegovy / Rybelsus and must demonstrate bioequivalence to be approved. The difference between a good and a bad generic lies in the manufacturer, not the molecule.
Key takeaways
- Bioequivalence means the generic delivers the same exposure within accepted limits.
- GMP status and batch documentation are the real quality signals.
- Generic Semaglutide is available across 0.25–2.4 mg pen; 3, 7, 14 mg oral.
- A batch-specific certificate of analysis should always be available on request.
How to audit a manufacturer
- 1
Confirm GMP certification
Verify a current WHO-GMP or equivalent certificate and its scope covers this dosage form.
- 2
Review the CoA
Check assay, dissolution, related substances and microbiological limits against the specification.
- 3
Check stability data
Confirm the shelf life is supported for storage 2–8 °C cold chain until first use.
- 4
Test the supply chain
Trace batch numbers from the manufacturer through to your receiving dock.
Brand vs quality generic
| Factor | Ozempic / Wegovy / Rybelsus | Generic Semaglutide |
|---|---|---|
| Active ingredient | Semaglutide | Semaglutide |
| Strengths | 0.25–2.4 mg pen; 3, 7, 14 mg oral | 0.25–2.4 mg pen; 3, 7, 14 mg oral |
| Regulatory basis | Full dossier | Bioequivalence to the reference product |
| Cost | Premium | Substantially lower landed cost |
| Documentation | Manufacturer pack | CoA, GMP certificate, stability data |
What we supply
ShiningRX sources generic Semaglutide only from audited, licensed manufacturing partners, and supplies full documentation with every consignment for prefilled pen / oral tablet presentations.
Semaglutide at a glance
| Attribute | Detail |
|---|---|
| Drug class | GLP-1 receptor agonist |
| Common brand | Ozempic / Wegovy / Rybelsus |
| Licensed use | type 2 diabetes and chronic weight management |
| Available strengths | 0.25–2.4 mg pen; 3, 7, 14 mg oral |
| Dosage form | prefilled pen / oral tablet |
| Typical onset | appetite effects within days, weight plateau at 60–68 weeks |
| Duration / dosing interval | 7-day half-life, once-weekly dosing |
| Storage | 2–8 °C cold chain until first use |
